Insilico Medicine Hong Kong Limited
Clinical trials sponsored by Insilico Medicine Hong Kong Limited, explained in plain language.
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people testing a new drug called ISM3412 for advanced solid tumors that have spread or can't be removed by surgery. Researchers will give increasing doses to 80 participants to find the safest and most effective amount. The main goals are to check for s…
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough cancers: first test of experimental drug begins
Disease control Recruiting nowThis is the first time a new drug called ISM6331 is being tested in people. The main goal is to find a safe dose and understand its side effects in 100 adults with advanced cancers like mesothelioma or other solid tumors that have not responded to standard treatments. Researchers…
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New pill tested to fight fatal lung scarring disease
Disease control Recruiting nowThis study is testing a new oral drug called INS018_055 in 40 adults with Idiopathic Pulmonary Fibrosis (IPF), a serious lung-scarring disease. The main goal is to check the drug's safety and how the body processes it over 12 weeks. Researchers will also look for early signs that…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New Gut-Targeted pill aims to calm ulcerative colitis flares
Disease control Recruiting nowThis study is testing an experimental oral medication called ISM5411 for adults with active ulcerative colitis. The drug is designed to work mainly in the gut to help protect the intestinal lining and reduce inflammation. Researchers will compare the drug to a placebo in 80 parti…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC